APA (7th ed.) Citation

S, F., C, H., L, X., S, S., P, A., N, C., . . . M, K. (2026). DX243 counteracts both acoustic trauma-induced reduction in cortical brain oscillations and cochlear synaptopathy. Frontiers in pharmacology, 16, 1673189. https://doi.org/10.3389/fphar.2025.1673189

Chicago Style (17th ed.) Citation

S, Fink, Harasztosi C, Xie L, Silvente S, Attali P, Caron N, Singer W, Rüttiger L, and Knipper M. "DX243 Counteracts Both Acoustic Trauma-induced Reduction in Cortical Brain Oscillations and Cochlear Synaptopathy." Frontiers in Pharmacology 16 (2026): 1673189. https://doi.org/10.3389/fphar.2025.1673189.

MLA (9th ed.) Citation

S, Fink, et al. "DX243 Counteracts Both Acoustic Trauma-induced Reduction in Cortical Brain Oscillations and Cochlear Synaptopathy." Frontiers in Pharmacology, vol. 16, 2026, p. 1673189, https://doi.org/10.3389/fphar.2025.1673189.